Marshall Wace North America L.P. purchased a new position in shares of Novadaq Technologies Inc (NASDAQ:NVDQ) (TSE:NDQ) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 190,838 shares of the medical research company’s stock, valued at approximately $2,290,000. Marshall Wace North America L.P. owned about 0.33% of Novadaq Technologies at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Bank of New York Mellon Corp increased its holdings in shares of Novadaq Technologies by 14.7% during the 1st quarter. Bank of New York Mellon Corp now owns 73,875 shares of the medical research company’s stock worth $576,000 after buying an additional 9,454 shares during the last quarter. OppenheimerFunds Inc. acquired a new stake in shares of Novadaq Technologies during the 1st quarter worth approximately $13,900,000. US Bancorp DE increased its holdings in shares of Novadaq Technologies by 0.8% during the 1st quarter. US Bancorp DE now owns 46,899 shares of the medical research company’s stock worth $365,000 after buying an additional 362 shares during the last quarter. Chicago Capital Management LLC acquired a new stake in shares of Novadaq Technologies during the 2nd quarter worth approximately $406,000. Finally, AXA increased its holdings in shares of Novadaq Technologies by 8.2% during the 1st quarter. AXA now owns 1,160,732 shares of the medical research company’s stock worth $9,042,000 after buying an additional 88,378 shares during the last quarter. Institutional investors and hedge funds own 75.38% of the company’s stock.

NVDQ has been the subject of a number of recent analyst reports. Stifel Nicolaus restated a “buy” rating and set a $10.00 price target on shares of Novadaq Technologies in a report on Friday, June 2nd. Zacks Investment Research upgraded shares of Novadaq Technologies from a “sell” rating to a “hold” rating in a report on Tuesday, May 9th. Canaccord Genuity downgraded shares of Novadaq Technologies from a “buy” rating to a “hold” rating and set a $11.75 price target for the company. in a report on Monday, July 10th. Northland Securities restated a “hold” rating and set a $11.75 price target on shares of Novadaq Technologies in a report on Monday, August 14th. Finally, BidaskClub upgraded shares of Novadaq Technologies from a “strong sell” rating to a “sell” rating in a report on Tuesday, August 22nd. One analyst has rated the stock with a sell rating, thirteen have given a hold rating and two have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $11.86.

Shares of Novadaq Technologies Inc (NASDAQ NVDQ) opened at 11.75 on Monday. Novadaq Technologies Inc has a 12-month low of $5.84 and a 12-month high of $12.74. The company has a 50-day moving average of $11.68 and a 200 day moving average of $8.98. The firm’s market cap is $679.41 million.

COPYRIGHT VIOLATION WARNING: “Marshall Wace North America L.P. Purchases New Holdings in Novadaq Technologies Inc (NVDQ)” was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The correct version of this article can be accessed at https://www.thecerbatgem.com/2017/09/04/marshall-wace-north-america-l-p-purchases-new-holdings-in-novadaq-technologies-inc-nvdq.html.

About Novadaq Technologies

NOVADAQ Technologies Inc is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed.

Institutional Ownership by Quarter for Novadaq Technologies (NASDAQ:NVDQ)

Receive News & Stock Ratings for Novadaq Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novadaq Technologies Inc and related stocks with our FREE daily email newsletter.